NEUROPATHIX, INC.: 10-Q filed 2017-11-14

Name: NEUROPATHIX, INC.: 10-Q filed 2017-11-14
Creator: NEUROPATHIX, INC.

What NEUROPATHIX, INC. reported in its quarterly report filed 2017-11-14 (fiscal Q3 2017): 25 published measures, 70 facts as tagged in accession 0001078782-17-001572.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-11-14
Fiscal period: fiscal Q3 2017
Accession: 0001078782-17-001572 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NEUROPATHIX, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-09-30	6,106	USD
At 2016-12-31	10,028	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-09-30	-33,986	USD
At 2016-12-31	-26,375	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-09-30	6,106	USD
At 2016-12-31	28	USD
At 2016-09-30	29	USD
At 2015-12-31	47,825	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-4,055	USD	92
2017-01-01 to 2017-09-30	-7,611	USD	273
2016-01-01 to 2016-12-31	-32,024	USD	366
2016-07-01 to 2016-09-30	-6,411	USD	92
2016-01-01 to 2016-09-30	-993	USD	274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	-14,429	USD	273
2016-01-01 to 2016-09-30	-31,172	USD	274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	20,507	USD	273
2016-01-01 to 2016-09-30	-16,624	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-09-30	-69,736	USD
At 2016-12-31	-62,125	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2017-07-01 to 2017-09-30	USD	92
2017-01-01 to 2017-09-30	USD	273
2016-07-01 to 2016-09-30	USD	92
2016-01-01 to 2016-09-30	USD	274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-4,055	USD	92
2017-01-01 to 2017-09-30	-7,611	USD	273
2016-07-01 to 2016-09-30	-6,411	USD	92
2016-01-01 to 2016-09-30	-993	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-09-30	6,106	USD
At 2016-12-31	10,028	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-09-30	40,092	USD
At 2016-12-31	36,403	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-09-30	0	USD
At 2016-12-31	16,818	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2017-09-30	0	USD
At 2016-12-31	10,000	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	4,055	USD	92
2017-01-01 to 2017-09-30	13,765	USD	273
2016-07-01 to 2016-09-30	6,411	USD	92
2016-01-01 to 2016-09-30	14,963	USD	274

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	0	USD	92
2017-01-01 to 2017-09-30	6,154	USD	273
2016-07-01 to 2016-09-30	0	USD	92
2016-01-01 to 2016-09-30	13,970	USD	274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	0	USD	92
2017-01-01 to 2017-09-30	0	USD	273
2016-07-01 to 2016-09-30	0	USD	92
2016-01-01 to 2016-09-30	21,000	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-09-30	9,530,000	shares
At 2016-12-31	9,530,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-09-30	34,797	USD
At 2016-12-31	34,797	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2017-09-30	-33,986	USD
At 2016-12-31	-26,375	USD
At 2015-12-31	5,649	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2017-09-30	23,710	USD
At 2016-12-31	21,123	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-4,055	USD	92
2017-01-01 to 2017-09-30	-7,611	USD	273
2016-07-01 to 2016-09-30	-6,411	USD	92
2016-01-01 to 2016-09-30	-993	USD	274

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	-7,611	USD	273
2016-01-01 to 2016-09-30	-993	USD	274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	4,055	USD	92
2017-01-01 to 2017-09-30	13,765	USD	273
2016-07-01 to 2016-09-30	6,411	USD	92
2016-01-01 to 2016-09-30	14,963	USD	274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	0	USD	273
2016-01-01 to 2016-09-30	0	USD	274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	-10,000	USD	273
2016-01-01 to 2016-09-30	10,000	USD	274

Inspect the source

Entity: NEUROPATHIX, INC. / CIK 0001615999
Captured: 2026-09-22 19:53 UTC
SEC response SHA-256: a975fe997e9854c9c4b078afe8f374baf90509e583bb6ae365c0229bf1a5418f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001615999.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))